Achyut Healthcare IPO: Globally established business in the Pharmaceutical Industry

Achyut Healthcare Limited was incorporated as a govt company, incorporated on January 11, 1996. The company is a private unlisted company and is classified as a company limited by shares with a business in Pharmaceutical Industry. In the year 2015, the company entered into the business of trading of Pharmaceutical products providing customized tailor made solutions to its clients and customers.

The company is registered in Ahmedabad (Gujarat) Registrar Office and the company operations are active. Presently, the company is into the trading business in both domestic as well as International markets in the countries namely UAE, Kenya and Nigeria.

The company is currently trading around 6 to 7 products based on the customers’ requirements and customisations both to domestic and international borders with each product being traded having its own strengths and significant key areas. Owing to the consistent efforts of the company, the annual top line sales of the company has crossed over 1 crores with no significant operational expenses.

They are engaged in trading of Cenzure, Arpimune, Azathioprine IP, Everomimus, Mycophenolate Mofetil USP, Mycophenolate Sodium USP, Sirolimus, Tacrolimus USP, Infrared thermometer, Ascorbic Acid Coated Vitamin C, Calcium carbonate oyster, Cellulose acetate Phthalate, Chlorthalidone IP, Croscarmellose Sod IP/USP, DIBasic Calcium Phosphate IP, DI Ethyl Phthlate, Diltiazem Hydrochloride IP, Easy Coat Fc Titanium Dioxide, Escitalopram IP, Escitalopram Oxalate, Favipiravir among many other products.

The revenue from operations from the fiscals 2021, 2020 and 2019 were ₹ 27.27 lacs, ₹ 33.41 Lacs and ₹ 66.74 Lacs respectively. Our EBITDA for the fiscals 2021, 2020 and 2019 were ₹ 1.02 Lacs, ₹ 1.89 Lacs and ₹ 1.34 Lacs respectively. The profit after tax for the Fiscals 2021, 2020 and 2019 was ₹ 0.74 Lacs, ₹ 1.40 Lacs and ₹ (1.46) Lacs respectively.